For biotech dealmakers, it’s everything, everywhere all at once

Submitted by admin on January 17, 2024 - 9:40am

Source:

Fierce Biotech

News Tags:

M&A

IPOs

reverse merger

venture capital

Headline:

For biotech dealmakers, it’s everything, everywhere all at once

snippet:

Biotech executives are reaching into a deep bag of tricks to come up with the best possible ways to live up to their ultimate potential. The dual-track option, where a company pursues both an IPO and an acquisition, is becoming not just the norm, but a necessity.

Search form

You are here

For biotech dealmakers, it’s everything, everywhere all at once

For biotech dealmakers, it’s everything, everywhere all at once